XRCC3 and breast carcinoma: In conclusion, the absence of mutations among breast cancer families and similar distribution of haplotypes between breast cancer cases and controls suggests that RAD51, XRCC3, and XRCC2 do not substantially contribute to familial breast cancer predisposition in the Finnish population.